Abstracts to be presented at the 2025 ISHLT Annual Meeting and Scientific Sessions will emphasize the expanding clinical evidence demonstrating the positive post-transplant impact of Paragonix's advanced organ preservation devices on patient outcomes.
WALTHAM, MA. April 2, 2025 – Paragonix Technologies, Inc., a pioneer in organ transplant products and services, is honored to announce the forthcoming release of new clinical data supporting the use of FDA-cleared and CE marked controlled hypothermic preservation devices and transplant services. These presentations compare and analyze post-transplant outcomes of patients, presented by a multi-center panel of clinical investigators representing the GUARDIAN Clinical Registries at the 45th ISHLT Annual Meeting and Scientific Sessions, located at the Hynes Convention Center in Boston, MA from April 27-30, 2025.
Clinical investigators will be sharing data and research related to Paragonix heart and lung devices (Paragonix SherpaPak®, BAROguard®, and LUNGguard®) in five oral presentations and four posters throughout the conference, including:
· Presentation: Lung Preservation at Controlled 4-8°C for Extended Criteria Donors Improves Outcome After Transplantation
o April 27, 2025, 3:00 PM - 3:08 PM - Ballroom B
· Presentation: Constant Airway Pressure Management System Leads to Improved Donor Lung Outcomes: Analysis of Ischemic Times >8 Hours
o April 27, 2025, 4:42 PM - 4:50 PM - Rooms 302-304-306
· Presentation: Impact of Controlled Hypothermic Preservation of Donor Hearts at 4-8°C on Late Post-Transplant Cardiac Allograft Vasculopathy
o April 28, 2025, 3:00 PM - 3:08 PM - Ballroom B
o April 28, 2025, 3:24 PM - 3:32 PM - Ballroom B
· Presentation: Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry
o April 28, 2025, 3:48 PM - 3:56 PM - Ballroom B
· Presentation: Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry
o April 29, 2025, 3:12 PM - 3:20 PM - Rooms 302-304-306
· Mini Presentation: Real-World Outcomes Using Controlled Moderate Hypothermia at 4-8°C for Lung Transplant: An Update from the Guardian-Lung Registry
o April 29, 2025, 5:18 PM - 5:22 PM - Ballroom B
· Mini Presentation: Outcomes Following Donation After Circulatory Death: Comparing Normothermic Regional Perfusion with Controlled 4-8°C Hypothermic Preservation and Extracorporeal Normothermic Perfusion
o April 29, 2025, 5:24 PM - 5:28 PM - Ballroom A
o April 29, 2025, 4:30 PM - 5:30 PM - Poster Hall
o April 29, 2024, 4:30 PM - 5:30 PM - Poster Hall
Additionally, Paragonix will be hosting two industry symposiums:
· Lung Symposium - Revolutionary Measures: Transformative Innovations Reshaping Lung Preservation
o Monday, April 28th, 11:45 AM to 12:45 PM - Room 311
· Heart Symposium - Mounting Evidence: Multifaceted Impact of Advanced Heart Preservation
o Tuesday, April 29th, 11:45 AM to 12:45 PM - Room 302/304/306
Both events will feature panels of leading surgeons and investigators of the GUARDIAN Registries as they explore the scientific foundation of advanced organ preservation and examine the associated impact on patient outcomes.
"We are excited to see the extensive research being presented at this year’s conference, which underscores the advancement of groundbreaking organ preservation technologies," said Dr. Lisa Anderson, President of Paragonix. "It is truly an honor to highlight and celebrate the important work of our distinguished colleagues, whose contributions are reshaping the future and elevating the standards of care in organ transplantation."
To visit the Paragonix Technologies exhibit and meet members of their team at ISHLT, visit booth #317.
L-736 Ver. 0